{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3CLpro", "Haritaki", "SARS-CoV-2", "medicinal plants", "tea"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32748969", "DateCompleted": {"Year": "2021", "Month": "01", "Day": "04"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.6802"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "34", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.", "Pagination": {"StartPage": "3411", "EndPage": "3419", "MedlinePgn": "3411-3419"}, "Abstract": {"AbstractText": ["The COVID-19 disease caused by the SARS-CoV-2 has emerged as a worldwide pandemic and caused huge damage to the lives and economy of more than hundred countries. As on May 10, 2020, more than 4,153,300 people stand infected from the virus due to an unprecedented rate of transmission and 282,700 have lost their lives because of the disease. In this context, medicinal plants may provide a way to treat the disease by targeting specific essential proteins of the virus. We screened about 51 medicinal plants and found that Tea (Camellia sinensis) and Haritaki (Terminalia chebula) has potential against SARS-COV-2 3CL<sup>pro</sup> , with an IC<sub>50</sub> for Green Tea as 8.9\u2009\u00b1\u20090.5 \u03bcg/ml and Haritaki 8.8\u2009\u00b1\u20090.5 \u03bcg/ml. The in-silico studies suggested that Tea component Thearubigins binds to the cysteine 145 of protease active site and could be a pharmacoactive molecule. We predict that the inhibition in protease activity may be able to halt the SARS-CoV-2 replication cycle and therefore, we propose Green Tea, Black Tea, and Haritaki plant extracts as potential therapeutic candidates for SARS-CoV-2 infection. Further investigation on role of bioactive constituents of extracts is needed to establish the molecular basis of inhibition and towards expedited drug discovery."], "CopyrightInformation": "\u00a9 2020 John Wiley & Sons, Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India."}], "LastName": "Upadhyay", "ForeName": "Saurabh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India."}], "LastName": "Tripathi", "ForeName": "Praveen K", "Initials": "PK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Morarji Desai National Institute of Yoga, New Delhi, India."}], "LastName": "Singh", "ForeName": "Manju", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India."}], "LastName": "Raghavendhar", "ForeName": "Siva", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India."}], "LastName": "Bhardwaj", "ForeName": "Mohit", "Initials": "M"}, {"Identifier": ["0000-0001-6134-7794"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India."}], "LastName": "Patel", "ForeName": "Ashok K", "Initials": "AK"}], "GrantList": [{"GrantID": "MI02217G", "Agency": "Indian Institute of Technology Delhi", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Camellia sinensis"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["enzymology"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Terminalia"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "Authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anand, K. , Ziebuhr, J. , Wadhwani, P. , Mesters, J. R. , & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti\u2010SARS drugs. Science, 300, 1763\u20131767. 10.1126/science.1085658", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Banik, S. , Biswas, S. , & Karmakar, S. (2018). Extraction, purification, and activity of protease from the leaves of Moringa oleifera . F1000Research, 7, 1151. 10.12688/f1000research.15642.1", "ArticleIdList": ["10.12688/f1000research.15642.1", "PMC6171725", "30345026"]}, {"Citation": "Cabrera, C. , Artacho, R. , & Gim\u00e9nez, R. (2006). Beneficial effects of green tea\u2014A review. Journal of the American College of Nutrition, 25, 79\u201399. 10.1080/07315724.2006.10719518", "ArticleIdList": ["10.1080/07315724.2006.10719518", "16582024"]}, {"Citation": "Capell, T. , Twyman, R. M. , Armario\u2010Najera, V. , Ma, J. K.\u2010C. , Schillberg, S. , & Christou, P. (2020). Potential applications of plant biotechnology against SARS\u2010CoV\u20102. Trends in Plant Science, 0, 635\u2013643. 10.1016/j.tplants.2020.04.009", "ArticleIdList": ["10.1016/j.tplants.2020.04.009", "PMC7181989", "32371057"]}, {"Citation": "Carneiro, B. M. , Batista, M. N. , Braga, A. C. S. , Nogueira, M. L. , & Rahal, P. (2016). The green tea molecule EGCG inhibits Zika virus entry. Virology, 496, 215\u2013218. 10.1016/j.virol.2016.06.012", "ArticleIdList": ["10.1016/j.virol.2016.06.012", "27344138"]}, {"Citation": "Chan, E. W. C. , Lim, Y. Y. , & Chew, Y. L. (2007). Antioxidant activity of Camellia sinensis leaves and tea from a lowland plantation in Malaysia. Food Chemistry, 102, 1214\u20131222. 10.1016/j.foodchem.2006.07.009", "ArticleIdList": ["10.1016/j.foodchem.2006.07.009"]}, {"Citation": "Chan, J. F. W. , Yuan, S. , Kok, K. H. , To, K. K. W. , Chu, H. , Yang, J. , \u2026 Yuen, K. Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person\u2010to\u2010person transmission: A study of a family cluster. The Lancet, 395, 514\u2013523. 10.1016/S0140-6736(20)30154-9", "ArticleIdList": ["10.1016/S0140-6736(20)30154-9", "PMC7159286", "31986261"]}, {"Citation": "Chen, C.\u2010N. , Lin, C. P. C. , Huang, K.\u2010K. , Chen, W.\u2010C. , Hsieh, H.\u2010P. , Liang, P.\u2010H. , & Hsu, J. T.\u2010A. (2005). Inhibition of SARS\u2010CoV 3C\u2010like protease activity by Theaflavin\u20103,3\u2032\u2010digallate (TF3). Evidence\u2010Based Complementary and Alternative Medicine, 2, 209\u2013215. 10.1093/ecam/neh081", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Cheng, H.\u2010Y. , Lin, C.\u2010C. , & Lin, T.\u2010C. (2002). Antiviral properties of Prodelphinidin B\u20102 3\u2032\u2010O\u2010Gallate from green tea leaf. Antiviral Chemistry & Chemotherapy, 13, 223\u2013229. 10.1177/095632020201300403", "ArticleIdList": ["10.1177/095632020201300403", "12495210"]}, {"Citation": "Cooper, R. , Morr\u00e9, D. J. , & Morr\u00e9, D. M. (2005a). Medicinal benefits of green tea: Part I. review of noncancer health benefits. Journal of Alternative and Complementary Medicine, 11, 521\u2013528. 10.1089/acm.2005.11.521", "ArticleIdList": ["10.1089/acm.2005.11.521", "15992239"]}, {"Citation": "Cooper, R. , Morr\u00e9, D. J. , & Morr\u00e9, D. M. (2005b). Medicinal benefits of green tea: Part II. Review of anticancer properties. Journal of Alternative and Complementary Medicine, 11, 639\u2013652. 10.1089/acm.2005.11.639", "ArticleIdList": ["10.1089/acm.2005.11.639", "16131288"]}, {"Citation": "Corsello, S. M. , Bittker, J. A. , Liu, Z. , Gould, J. , McCarren, P. , Hirschman, J. E. , \u2026 Golub, T. R. (2017). The drug repurposing hub: A next\u2010generation drug library and information resource. Nature Medicine, 23, 405\u2013408. 10.1038/nm.4306", "ArticleIdList": ["10.1038/nm.4306", "PMC5568558", "28388612"]}, {"Citation": "Cupp\u2010Enyard, C. (2008). Sigma's non\u2010specific protease activity assay\u2014Casein as a substrate. Journal of Visualized Experiments, (19), e899. 10.3791/899", "ArticleIdList": ["10.3791/899", "PMC2872977", "19066538"]}, {"Citation": "Gorbalenya, A. E. , Baker, S. C. , Baric, R. S. , de Groot, R. J. , Drosten, C. , Gulyaeva, A. A. , \u2026 Ziebuhr, J. (2020). The species Severe acute respiratory syndrome\u2010related coronavirus: classifying 2019\u2010nCoV and naming it SARS\u2010CoV\u20102. Nature Microbiology, 5, 536\u2013544. 10.1038/s41564-020-0695-z", "ArticleIdList": ["10.1038/s41564-020-0695-z", "PMC7095448", "32123347"]}, {"Citation": "Hilgenfeld, R. (2014). From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. The FEBS Journal, 281, 4085\u20134096. 10.1111/febs.12936", "ArticleIdList": ["10.1111/febs.12936", "PMC7163996", "25039866"]}, {"Citation": "Karamese, M. , Aydogdu, S. , Karamese, S. A. , Altoparlak, U. , & Gundogdu, C. (2015). Preventive effects of a major component of green tea, epigallocathechin\u20103\u2010gallate, on hepatitis\u2010B virus DNA replication. Asian Pacific Journal of Cancer Prevention, 16, 4199\u20134202. 10.7314/apjcp.2015.16.10.4199", "ArticleIdList": ["10.7314/apjcp.2015.16.10.4199", "26028072"]}, {"Citation": "Kesharwani, A. , Polachira, S. K. , Nair, R. , Agarwal, A. , Mishra, N. N. , & Gupta, S. K. (2017). Anti\u2010HSV\u20102 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complementary and Alternative Medicine, 17, 110. 10.1186/s12906-017-1620-8", "ArticleIdList": ["10.1186/s12906-017-1620-8", "PMC5310005", "28196487"]}, {"Citation": "Lee, D. , Boo, K. H. , Woo, J. K. , Duan, F. , Lee, K. H. , Kwon, T. K. , \u2026 Lee, D. S. (2011). Anti\u2010bacterial and anti\u2010viral activities of extracts from Terminalia chebula barks. Journal of Applied Biological Chemistry, 54, 295\u2013298. 10.3839/jksabc.2011.046", "ArticleIdList": ["10.3839/jksabc.2011.046"]}, {"Citation": "Lee, Y. H. , Jang, Y. H. , Kim, Y. S. , Kim, J. , & Seong, B. L. (2018). Evaluation of green tea extract as a safe personal hygiene against viral infections. Journal of Biological Engineering, 12, 1. 10.1186/s13036-017-0092-1", "ArticleIdList": ["10.1186/s13036-017-0092-1", "PMC5759362", "29339972"]}, {"Citation": "Li, P. , Du, R. , Wang, Y. , Hou, X. , Wang, L. , Zhao, X. , \u2026 Cui, Q. (2020). Identification of Chebulinic acid and Chebulagic acid as novel influenza viral neuraminidase inhibitors. Frontiers in Microbiology, 11, 182. 10.3389/fmicb.2020.00182", "ArticleIdList": ["10.3389/fmicb.2020.00182", "PMC7093024", "32256457"]}, {"Citation": "Liu, K. , Chen, Y. , Lin, R. , & Han, K. (2020). Clinical features of COVID\u201019 in elderly patients: A comparison with young and middle\u2010aged patients. The Journal of Infection, 80, e14\u2013e18. 10.1016/j.jinf.2020.03.005", "ArticleIdList": ["10.1016/j.jinf.2020.03.005", "PMC7102640", "32171866"]}, {"Citation": "Mahmood, M. S. , M\u00e1rtinez, J. L. , Aslam, A. , Rafique, A. , Vinet, R. , Laurido, C. , \u2026 Ali, S. (2016). Antiviral effects of green tea (Camellia sinensis) against pathogenic viruses in human and animals (a mini\u2010review). African Journal of Traditional, Complementary, and Alternative Medicines, 13(2), 176\u2013184. 10.4314/ajtcam.v13i2.21", "ArticleIdList": ["10.4314/ajtcam.v13i2.21"]}, {"Citation": "Newman, D. J. , & Cragg, G. M. (2007). Natural products as sources of new drugs over the last 25\u2009years. Journal of Natural Products, 70, 461\u2013477. 10.1021/np068054v", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Raghavendhar, S. , Tripati, P. K. , Ray, P. , & Patel, A. K. (2019). Evaluation of medicinal herbs for anti\u2010CHIKV activity. Virology, 533, 45\u201349. 10.1016/j.virol.2019.04.007", "ArticleIdList": ["10.1016/j.virol.2019.04.007", "31082733"]}, {"Citation": "Studier, F. W. (2005). Protein production by auto\u2010induction in high density shaking cultures. Protein Expression and Purification, 41, 207\u2013234. 10.1016/j.pep.2005.01.016", "ArticleIdList": ["10.1016/j.pep.2005.01.016", "15915565"]}, {"Citation": "Varga, Z. , Flammer, A. J. , Steiger, P. , Haberecker, M. , Andermatt, R. , Zinkernagel, A. S. , \u2026 Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID\u201019. The Lancet, 395, 1417\u20131418. 10.1016/S0140-6736(20)30937-5", "ArticleIdList": ["10.1016/S0140-6736(20)30937-5", "PMC7172722", "32325026"]}, {"Citation": "Xu, L. , Liu, J. , Lu, M. , Yang, D. , & Zheng, X. (2020). Liver injury during highly pathogenic human coronavirus infections. Liver International, 40, 998\u20131004. 10.1111/liv.14435", "ArticleIdList": ["10.1111/liv.14435", "PMC7228361", "32170806"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "11"}, {"Year": "2020", "Month": "6", "Day": "10"}, {"Year": "2020", "Month": "6", "Day": "23"}, {"Year": "2020", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32748969", "PMC7436756", "10.1002/ptr.6802"]}}], "PubmedBookArticle": []}